Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice
Sign Up to like & getrecommendations! Published in 2023 at "Drug Delivery"
DOI: 10.1080/10717544.2023.2183821
Abstract: Abstract Inflammatory bowel disease (IBD) is one of the most common intestinal disorders, with increasing global incidence and prevalence. Numerous therapeutic drugs are available but require intravenous administration and are associated with high toxicity and… read more here.
Keywords: liposomal delivery; budesonide; oral liposomal; delivery activatable ... See more keywords